Keith Lamont Cummings, Chief Financial Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 24,002 shares at $1.28 ($31K) on 2026-01-20, disclosed to the SEC on 2026-01-22.
Scheduled sale ($31k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PLRX | SELL | 2024-01-19 | $337K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $712K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $528K | — | Filing → |